UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Telomere Length Is Predictive of Breast Cancer Risk in BRCA2 Mutation Carriers

Cancer epidemiology, biomarkers & prevention, 2017-08, Vol.26 (8), p.1248-1254

2017

Link zum Volltext

Verfügbarkeit prüfen

Systematic pathway enrichment analysis of a genome-wide association study on breast cancer survival reveals an influence of genes involved in cell adhesion and calcium signaling on the patients' clinical outcome

PloS one, 2014-06, Vol.9 (6), p.e98229-e98229

2014

Link zum Volltext

Verfügbarkeit prüfen

Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes

Breast cancer research : BCR, 2009-01, Vol.11 (4), p.R47-R47

2009

Link zum Volltext

Verfügbarkeit prüfen

Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency

Cancer research (Chicago, Ill.), 2017-09, Vol.77 (18), p.4755-4762

2017

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer

Breast cancer research : BCR, 2006-01, Vol.8 (4), p.R38-R38

2006

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer risk factors and age at diagnosis: An Icelandic cohort study

International journal of cancer, 2002-04, Vol.98 (4), p.604-608

2002

Link zum Volltext

Verfügbarkeit prüfen

A DNA methylation-based definition of biologically distinct breast cancer subtypes

Molecular oncology, 2015-03, Vol.9 (3), p.555-568

2015

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker

Carcinogenesis (New York), 2013-01, Vol.34 (1), p.102-108

2013

Link zum Volltext

Verfügbarkeit prüfen

Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer

Cancer cell, 2010-11, Vol.18 (5), p.499

2010

Link zum Volltext

Verfügbarkeit prüfen

Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome

Breast cancer research and treatment, 2011-12, Vol.130 (3), p.905-916

2011

Link zum Volltext

Verfügbarkeit prüfen

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

Clinical cancer research, 2006-02, Vol.12 (4), p.1157-1167

2006

Link zum Volltext

Verfügbarkeit prüfen

Population-Based Study of Changing Breast Cancer Risk in Icelandic BRCA2 Mutation Carriers, 1920–2000

JNCI : Journal of the National Cancer Institute, 2006-01, Vol.98 (2), p.116-122

2006

Link zum Volltext

Verfügbarkeit prüfen

Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers

British journal of cancer, 2016-09, Vol.115 (7), p.776-783

2016

Link zum Volltext

Verfügbarkeit prüfen

A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19), p.5608-5619

2014

Link zum Volltext

Verfügbarkeit prüfen

A candidate CpG SNP approach identifies a breast cancer associated ESR1‐SNP

International journal of cancer, 2011-10, Vol.129 (7), p.1689-1698

2011

Link zum Volltext

Verfügbarkeit prüfen

Cytogenetic polyclonality of breast carcinomas: Association with Clinico-Pathological Characteristics and Outcome

Genes chromosomes & cancer, 2011-11, Vol.50 (11), p.930-939

2011

Link zum Volltext

Verfügbarkeit prüfen

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression

Breast cancer research : BCR, 2011-09, Vol.13 (5), p.R95-R95

2011

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

JNCI : Journal of the National Cancer Institute, 2007-06, Vol.99 (12), p.929-935

2007

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy

JNCI cancer spectrum, 2020-04, Vol.4 (2), p.pkz100-pkz100

2020

Link zum Volltext

Verfügbarkeit prüfen

DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity

Oncogene, 2003-01, Vol.22 (3), p.445-450

2003

Link zum Volltext

Verfügbarkeit prüfen

Tumour diploidy and survival in breast cancer patients with BRCA2 mutations

Breast cancer research and treatment, 2013-07, Vol.140 (2), p.375-384

2013

Link zum Volltext

Verfügbarkeit prüfen

The Icelandic founder mutation BRCA2 999del5: analysis of expression

Breast cancer research : BCR, 2004-01, Vol.6 (4), p.R284-R290, Article R284

2004

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer risk associated with AURKA 91T → A polymorphism in relation to BRCA mutations

Cancer letters, 2007-06, Vol.250 (2), p.206-212

2007

Link zum Volltext

Verfügbarkeit prüfen

BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts

Cellular oncology : the official journal of the International Society for Cellular Oncology, 2009, Vol.31 (3), p.191-201

2009

Link zum Volltext

Verfügbarkeit prüfen

Aurora-A amplification associated with BRCA2 mutation in breast tumours

Cancer letters, 2007-04, Vol.248 (1), p.96-102

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Telomere Length Is Predictive of Breast Cancer Risk in BRCA2 Mutation Carriers

Systematic pathway enrichment analysis of a genome-wide association study on breast cancer survival reveals an influence of genes involved in cell adhesion and calcium signaling on the patients' clinical outcome

Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes

Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer

Breast cancer risk factors and age at diagnosis: An Icelandic cohort study

A DNA methylation-based definition of biologically distinct breast cancer subtypes

DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker

Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer

Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

Population-Based Study of Changing Breast Cancer Risk in Icelandic BRCA2 Mutation Carriers, 1920–2000

Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers

A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition

A candidate CpG SNP approach identifies a breast cancer associated ESR1‐SNP

Cytogenetic polyclonality of breast carcinomas: Association with Clinico-Pathological Characteristics and Outcome

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy

DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity

Tumour diploidy and survival in breast cancer patients with BRCA2 mutations

The Icelandic founder mutation BRCA2 999del5: analysis of expression

Breast cancer risk associated with AURKA 91T → A polymorphism in relation to BRCA mutations

BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts

Aurora-A amplification associated with BRCA2 mutation in breast tumours

Aktive Filter

Suchergebnisse filtern